Carlyle, the investment manager whose portfolio companies employ more than 700,000 people globally, is stepping into the economic data void left by the US government shutdown https://t.co/opYUEkLePx ...

Core Insights - Acentra Health's Chief People Officer, Kelly Schlageter, has been recognized as a 2025 Women in Leadership honoree by Virginia Business for her exceptional leadership and commitment to inclusivity [1][5] Company Initiatives - Under Schlageter's leadership, Acentra Health employees contributed over 3,000 hours of volunteer service and more than $330,000 in philanthropic contributions in 2024, showcasing the company's commitment to corporate social responsibility [2] - The company has implemented strategic initiatives to enhance workforce engagement and mental wellness, including expanded employee wellness offerings [3] Leadership and Culture - Schlageter has fostered a people-first mindset and a values-driven culture at Acentra Health, emphasizing empathy, clarity, and action, which has contributed to a thriving workplace [3] - Acentra Health has united three organizations under a shared identity and purpose through a successful merger, with Schlageter playing a key leadership role in this process [3] Advocacy and Recognition - Schlageter is a long-time advocate for equity and LGBTQ+ inclusion, receiving national recognition for her contributions, including the Washington Business Journal's Business of Pride honor [4] - She serves on the Northern Virginia Chamber of Commerce Board of Directors and is a member of The Economic Club of Washington, D.C., further demonstrating her commitment to social impact [4] Company Overview - Acentra Health combines public sector knowledge, clinical expertise, and technological innovation to modernize healthcare experiences for various partners, aiming to accelerate better health outcomes [6]

Carlyle is now the frontrunner to buy BASF’s coatings business after KPS Capital exited the bid https://t.co/W2xQoQaQBh ...

TORONTO, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) will release its third quarter 2025 operating and financial results after the market closes on Tuesday October 28, 2025. The Company will host a conference call and webcast to discuss the results on Wednesday October 29, 2025, at 9:00 a.m. Eastern Time. Details for the conference call and webcast are included below. Webcast Participants can access the webcast at the following webcast link.An ar ...

"We see power investing as a significant opportunity set for us," Carlyle's Pooja Goyal says #BBGWomenMoneyPower https://t.co/D71n0UVSBN https://t.co/VYkSbsLzCY ...

Core Insights - Acentra Health's Chief Health and Informatics Officer, Dr. Ryan Bosch, has been recognized as a 2025 Innovator in Health Care by the Washington Business Journal for his contributions to healthcare innovation [1][2] Company Overview - Acentra Health is a technology and health solutions company focused on improving health outcomes for clients and the populations they serve [1] - The company combines public sector knowledge, clinical expertise, and technological innovation to modernize healthcare experiences for various partners [4] Leadership and Contributions - Dr. Bosch is a practicing internal medicine physician and a U.S. Air Force veteran, known for integrating social risk data with clinical and claims information to enhance care delivery in state Medicaid programs [2] - Under Dr. Bosch's leadership, Acentra Health has improved health outcomes for vulnerable populations across 47 states [2][3] - His efforts in data modernization have enabled states to utilize predictive analysis to address health disparities and reduce program costs [3] Innovation and Impact - Dr. Bosch's work focuses on transforming complex data into actionable insights, allowing public and commercial sector partners to provide smarter, more connected care [3] - The company aims to raise the standard of care while advancing the field of population health through data-driven strategies [3]

for a look at the economy following last week's PCE report. To join us right now is Carlile, head of global research, Jason Thomas. Good morning to you, sir.I think we're all trying to figure out where we really are. So, where are we. >> Well, I I think when you think when you look at the PCE report, I think the first point to make is that the Fed has not hit its inflation target in now 54 months.That's quite a long time. There are about three million uh children who are enrolled in elementary school in the ...

Economic Overview - The Federal Reserve has not met its inflation target for 54 months, indicating a prolonged period of excess inflation [1][2] - Approximately three million children have been born since the Fed last achieved its inflation target, highlighting the significance of this duration [2] Inflation Insights - Current excess inflation is compounded on a 20% increase in the consumer price level, emphasizing the severity of the situation [3] - The core PCE inflation rate is reported at 2.9%, which some may downplay, but it remains a significant concern given the context of previous price increases [4][6] Policy Considerations - The discussion around tariffs suggests they only affect a small portion of the PCE index, with services unaffected by tariffs still increasing at an annualized rate of 3.5% [5][6] - There is a concern that aggressive rate cuts could lead to upward pressure on yields, as seen in previous instances where rate cuts were followed by increases in long-term yields [12] Future Expectations - The expectation is that the Fed should take time to assess the current economic conditions rather than rushing into rate cuts, especially in light of a significant capital expenditure boom [10][11] - The forward curve indicates a potential drop in rates to 3% by the end of next year, which may not align with the current economic environment characterized by low unemployment and high capital expenditures [15][16] Tariff Implications - There are complexities surrounding tariffs, including the potential for the president to utilize various statutory authorities to impose or maintain tariffs, regardless of legal challenges [17][18]

Core Viewpoint - The potential merger between The Carlyle Group Inc. and Macquarie Group has stalled due to improved investor confidence in Carlyle's performance under CEO Harvey Schwartz, reducing the need for the merger [1][8]. Group 1: Merger Details - The proposed merger would have created a $1 trillion investment powerhouse, positioning the combined firm ahead of competitors like KKR & Co. Inc. and Ares Management Corporation in terms of assets under management (AUM) [2]. - Carlyle's vulnerability to a merger was highlighted in 2022, following the departure of CEO Kewsong Lee, which led to internal instability and lagging valuation compared to peers [3]. Group 2: Leadership Impact - The appointment of Harvey Schwartz as CEO in February 2023 significantly improved investor sentiment, with Carlyle raising $51 billion in fresh capital over the past year, particularly in high-growth areas [4][8]. - Carlyle's strategic initiatives, including a merger of its lending subsidiary and a partnership with Citigroup, have further strengthened its position and diminished the need for a transformational merger [5][6]. Group 3: Performance Metrics - Carlyle's shares have increased by 58.8% over the past year, significantly outperforming the industry growth of 11.3% [7].

Group 1 - Carlyle has hired two senior executives for its direct-lending business [1] - The hiring aims to increase Carlyle's share in a growing market [1]